Your browser doesn't support javascript.
loading
Loss-of-Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities.
Steel, Dora; Zech, Michael; Zhao, Chen; Barwick, Katy E S; Burke, Derek; Demailly, Diane; Kumar, Kishore R; Zorzi, Giovanna; Nardocci, Nardo; Kaiyrzhanov, Rauan; Wagner, Matias; Iuso, Arcangela; Berutti, Riccardo; Skorvánek, Matej; Necpál, Ján; Davis, Ryan; Wiethoff, Sarah; Mankad, Kshitij; Sudhakar, Sniya; Ferrini, Arianna; Sharma, Suvasini; Kamsteeg, Erik-Jan; Tijssen, Marina A; Verschuuren, Corien; van Egmond, Martje E; Flowers, Joanna M; McEntagart, Meriel; Tucci, Arianna; Coubes, Philippe; Bustos, Bernabe I; Gonzalez-Latapi, Paulina; Tisch, Stephen; Darveniza, Paul; Gorman, Kathleen M; Peall, Kathryn J; Bötzel, Kai; Koch, Jan C; Kmiec, Tomasz; Plecko, Barbara; Boesch, Sylvia; Haslinger, Bernhard; Jech, Robert; Garavaglia, Barbara; Wood, Nick; Houlden, Henry; Gissen, Paul; Lubbe, Steven J; Sue, Carolyn M; Cif, Laura; Mencacci, Niccolò E.
Afiliación
  • Steel D; Department of Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Zech M; Department of Neurology, Great Ormond Street Hospital, London, UK.
  • Zhao C; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
  • Barwick KES; Institute of Human Genetics, Technical University of Munich, Munich, Germany.
  • Burke D; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
  • Demailly D; Department of Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Kumar KR; Enzyme Laboratory, Great Ormond Street Hospital for Children, London, UK.
  • Zorzi G; Unités des Pathologies Cérébrales Résistantes, Département de Neurochirurgie, Centre Hospitalier Universitaire, Montpellier, France.
  • Nardocci N; Department of Neurogenetics, Kolling Institute of Medical Research, University of Sydney and Northern Sydney Local Health District, Sydney, New South Wales, Australia.
  • Kaiyrzhanov R; Molecular Medicine Laboratory, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
  • Wagner M; Translational Genomics, Kinghorn Centre for Clinical Genomics, Garvan Institute for Medical Research, Sydney, New South Wales, Australia.
  • Iuso A; Department of Neurogenetics, University of Sydney and Northern Sydney Local Health District, Sydney, New South Wales, Australia.
  • Berutti R; Department of Child Neurology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Skorvánek M; Department of Child Neurology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Necpál J; Department of Neuromuscular Diseases, University College London, Queen Square, Institute of Neurology, London, UK.
  • Davis R; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
  • Wiethoff S; Institute of Human Genetics, Technical University of Munich, Munich, Germany.
  • Mankad K; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
  • Sudhakar S; Institute of Human Genetics, Technical University of Munich, Munich, Germany.
  • Ferrini A; Institute of Human Genetics, Technical University of Munich, Munich, Germany.
  • Sharma S; Department of Neurology, P. J. Safarik University, Kosice, Slovak Republic.
  • Kamsteeg EJ; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
  • Tijssen MA; Department of Neurology, Zvolen Hospital, Zvolen, Slovakia.
  • Verschuuren C; Department of Neurogenetics, Kolling Institute of Medical Research, University of Sydney and Northern Sydney Local Health District, Sydney, New South Wales, Australia.
  • van Egmond ME; Translational Genomics, Kinghorn Centre for Clinical Genomics, Garvan Institute for Medical Research, Sydney, New South Wales, Australia.
  • Flowers JM; Department of Neurogenetics, University of Sydney and Northern Sydney Local Health District, Sydney, New South Wales, Australia.
  • McEntagart M; UCL Queen Square Institute of Neurology, London, UK.
  • Tucci A; Department of Neurodegenerative Disease, Hertie-Institute for Clinical Brain Research and Center for Neurology, University of Tübingen, Tübingen, Germany.
  • Coubes P; Department of Radiology, Great Ormond Street Hospital for Children, London, UK.
  • Bustos BI; Department of Radiology, Great Ormond Street Hospital for Children, London, UK.
  • Gonzalez-Latapi P; Department of Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Tisch S; Neurology Division, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi, India.
  • Darveniza P; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gorman KM; Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Peall KJ; Expertise Center Movement Disorders Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Bötzel K; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Koch JC; Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Kmiec T; Expertise Center Movement Disorders Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Plecko B; Department of Neurology, St. George's Hospital, London, UK.
  • Boesch S; Department of Clinical Genetics, St. George's Hospital, London, UK.
  • Haslinger B; Genomics England, London, UK.
  • Jech R; Unités des Pathologies Cérébrales Résistantes, Département de Neurochirurgie, Centre Hospitalier Universitaire, Montpellier, France.
  • Garavaglia B; Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Wood N; Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Houlden H; Department of Neurology, St. Vincent's Hospital, Sydney, Australia.
  • Gissen P; Department of Neurology, St. Vincent's Hospital, Sydney, Australia.
  • Lubbe SJ; Department of Neurology and Clinical Neurophysiology, Children's Health Ireland at Temple Street, Dublin, Ireland.
  • Sue CM; UCD School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.
  • Cif L; University of Cardiff, Cardiff, Wales, UK.
  • Mencacci NE; Department of Neurology, Ludwig Maximilian University, Munich, Germany.
Ann Neurol ; 88(5): 867-877, 2020 11.
Article en En | MEDLINE | ID: mdl-32808683
ABSTRACT

OBJECTIVES:

The majority of people with suspected genetic dystonia remain undiagnosed after maximal investigation, implying that a number of causative genes have not yet been recognized. We aimed to investigate this paucity of diagnoses.

METHODS:

We undertook weighted burden analysis of whole-exome sequencing (WES) data from 138 individuals with unresolved generalized dystonia of suspected genetic etiology, followed by additional case-finding from international databases, first for the gene implicated by the burden analysis (VPS16), and then for other functionally related genes. Electron microscopy was performed on patient-derived cells.

RESULTS:

Analysis revealed a significant burden for VPS16 (Fisher's exact test p value, 6.9 × 109 ). VPS16 encodes a subunit of the homotypic fusion and vacuole protein sorting (HOPS) complex, which plays a key role in autophagosome-lysosome fusion. A total of 18 individuals harboring heterozygous loss-of-function VPS16 variants, and one with a microdeletion, were identified. These individuals experienced early onset progressive dystonia with predominant cervical, bulbar, orofacial, and upper limb involvement. Some patients had a more complex phenotype with additional neuropsychiatric and/or developmental comorbidities. We also identified biallelic loss-of-function variants in VPS41, another HOPS-complex encoding gene, in an individual with infantile-onset generalized dystonia. Electron microscopy of patient-derived lymphocytes and fibroblasts from both patients with VPS16 and VPS41 showed vacuolar abnormalities suggestive of impaired lysosomal function.

INTERPRETATION:

Our study strongly supports a role for HOPS complex dysfunction in the pathogenesis of dystonia, although variants in different subunits display different phenotypic and inheritance characteristics. ANN NEUROL 2020;88867-877.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades por Almacenamiento Lisosomal / Proteínas de Transporte Vesicular / Distonía Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Neurol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades por Almacenamiento Lisosomal / Proteínas de Transporte Vesicular / Distonía Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Neurol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido